Rocket Pharmaceuticals, Inc. (RCKT) Financials

RCKT Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 566.3 million 73.8 million
2023-09-30 598.8 million 57.7 million
2023-06-30 461.8 million 58.8 million
2023-03-31 514.8 million 55.9 million

RCKT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -34.0 million 9.9 million
2023-09-30 -61.8 million 10.3 million
2023-06-30 -55.0 million 10.2 million
2023-03-31 -60.6 million 8.9 million

RCKT Net Income

No data available :(

RCKT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 373.2 million - 25.0 million
2023-09-30 437.2 million - 25.2 million
2023-06-30 307.0 million - 25.4 million
2023-03-31 331.1 million - 25.4 million

RCKT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 84.0 million
2023-09-30 82.6 million
2023-06-30 80.5 million
2023-03-31 79.5 million

RCKT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 4.6 million 41.7 million 21.5 million -
2023-09-30 4.7 million 46.8 million 18.6 million -
2023-06-30 4.1 million 51.4 million 17.4 million -
2023-03-31 3.0 million 46.4 million 15.8 million -

RCKT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 10.3 million 5.2 million
2023-09-30 - 1.8 million
2023-06-30 - 1.7 million
2023-03-31 - 1.7 million

RCKT

Price: $23.36

52 week price:
14.89
32.53

Earnings Per Share: -2.92 USD

P/E Ratio: -9.06

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 607900

Market Capitalization: 2.2 billion

Links: